Viking Therapeutics
VKTX
VKTX
372 hedge funds and large institutions have $6.56B invested in Viking Therapeutics in 2024 Q1 according to their latest regulatory filings, with 201 funds opening new positions, 77 increasing their positions, 87 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
47% more call options, than puts
Call options by funds: $730M | Put options by funds: $496M
4.69% less ownership
Funds ownership: 77.91% → 73.22% (-4.7%)
11% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 87
Holders
372
Holding in Top 10
13
Calls
$730M
Puts
$496M
Top Buyers
| 1 | +$294M | |
| 2 | +$197M | |
| 3 | +$110M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$85.1M |
| 5 |
PA
Perceptive Advisors
New York
|
+$81.5M |
Top Sellers
| 1 | -$332M | |
| 2 | -$197M | |
| 3 | -$175M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$173M |
| 5 |
Morgan Stanley
New York
|
-$166M |